Literature DB >> 31266787

Embracing the science of value in health.

Murray Krahn1, Stirling Bryan2, Karen Lee2, Peter J Neumann2.   

Abstract

Mesh:

Year:  2019        PMID: 31266787      PMCID: PMC6606418          DOI: 10.1503/cmaj.181606

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  20 in total

1.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

Review 2.  Bias in published cost effectiveness studies: systematic review.

Authors:  Chaim M Bell; David R Urbach; Joel G Ray; Ahmed Bayoumi; Allison B Rosen; Dan Greenberg; Peter J Neumann
Journal:  BMJ       Date:  2006-02-22

3.  Welfarism vs. extra-welfarism.

Authors:  Werner B F Brouwer; Anthony J Culyer; N Job A van Exel; Frans F H Rutten
Journal:  J Health Econ       Date:  2007-11-29       Impact factor: 3.883

4.  The next step in guideline development: incorporating patient preferences.

Authors:  Murray Krahn; Gary Naglie
Journal:  JAMA       Date:  2008-07-23       Impact factor: 56.272

5.  A glimpse into the black box of cost-effectiveness analyses.

Authors:  Ava A John-Baptiste; Chaim Bell
Journal:  CMAJ       Date:  2011-03-14       Impact factor: 8.262

6.  Understanding the costs of cancer care before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study.

Authors:  Claire de Oliveira; Karen E Bremner; Reka Pataky; Nadia Gunraj; Kelvin Chan; Stuart Peacock; Murray D Krahn
Journal:  CMAJ Open       Date:  2013-01-16

7.  Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.

Authors:  Karl Claxton; Steve Martin; Marta Soares; Nigel Rice; Eldon Spackman; Sebastian Hinde; Nancy Devlin; Peter C Smith; Mark Sculpher
Journal:  Health Technol Assess       Date:  2015-02       Impact factor: 4.014

8.  Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

Authors:  Andrew J Palmer; Philip Clarke; Alastair Gray; Jose Leal; Adam Lloyd; David Grant; James Palmer; Volker Foos; Mark Lamotte; William Hermann; Jacob Barhak; Michael Willis; Ruth Coleman; Ping Zhang; Phil McEwan; Jonathan Betz Brown; Ulf Gerdtham; Elbert Huang; Andrew Briggs; Katarina Steen Carlsson; William Valentine
Journal:  Value Health       Date:  2013-04-18       Impact factor: 5.725

9.  From efficacy to equity: Literature review of decision criteria for resource allocation and healthcare decisionmaking.

Authors:  Lalla Aïda Guindo; Monika Wagner; Rob Baltussen; Donna Rindress; Janine van Til; Paul Kind; Mireille M Goetghebeur
Journal:  Cost Eff Resour Alloc       Date:  2012-07-18

10.  A Time Trade-off-derived Value Set of the EQ-5D-5L for Canada.

Authors:  Feng Xie; Eleanor Pullenayegum; Kathy Gaebel; Nick Bansback; Stirling Bryan; Arto Ohinmaa; Lise Poissant; Jeffrey A Johnson
Journal:  Med Care       Date:  2016-01       Impact factor: 2.983

View more
  6 in total

1.  Cost-effectiveness analysis should be mandatory in clinical-effectiveness research.

Authors:  Bharath Kumar Tirupakuzhi Vijayaraghavan; Xavier Willaert; Brian H Cuthbertson
Journal:  CMAJ       Date:  2019-10-15       Impact factor: 8.262

2.  Economic evaluation alongside the Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial (E-PROSPECT): study protocol.

Authors:  Vincent Issac Lau; Deborah J Cook; Robert Fowler; Bram Rochwerg; Jennie Johnstone; François Lauzier; John C Marshall; John Basmaji; Diane Heels-Ansdell; Lehana Thabane; Feng Xie
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

3.  Cost-effectiveness of remdesivir plus usual care versus usual care alone for hospitalized patients with COVID-19: an economic evaluation as part of the Canadian Treatments for COVID-19 (CATCO) randomized clinical trial.

Authors:  Vincent I Lau; Robert Fowler; Ruxandra Pinto; Alain Tremblay; Sergio Borgia; François M Carrier; Matthew P Cheng; John Conly; Cecilia T Costiniuk; Peter Daley; Erick Duan; Madeleine Durand; Patricia S Fontela; George Farjou; Mike Fralick; Anna Geagea; Jennifer Grant; Yoav Keynan; Kosar Khwaja; Nelson Lee; Todd C Lee; Rachel Lim; Conar R O'Neil; Jesse Papenburg; Makeda Semret; Michael Silverman; Wendy Sligl; Ranjani Somayaji; Darrell H S Tan; Jennifer L Y Tsang; Jason Weatherald; Cedric Philippe Yansouni; Ryan Zarychanski; Srinivas Murthy
Journal:  CMAJ Open       Date:  2022-09-06

4.  Reality Check 2: The Cost-Effectiveness of Policy Disallowing Body Checking in Non-Elite 13- to 14-Year-Old Ice Hockey Players.

Authors:  Gillian R Currie; Raymond Lee; Luz Palacios-Derflingher; Brent Hagel; Amanda M Black; Shelina Babul; Martin Mrazik; Deborah A Marshall; Carolyn A Emery
Journal:  Int J Environ Res Public Health       Date:  2021-06-11       Impact factor: 3.390

5.  Comparing the Clinical and Cost-Effectiveness of Abdominal-based Autogenous Tissue and Tissue-Expander Implant: A Feasibility Study.

Authors:  Achilles Thoma; Ronen Avram; Arianna Dal Cin; Jessica Murphy; Eric Duku; Feng Xie
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-11

6.  Cost-effectiveness Analysis of Abdominal-based Autogenous Tissue and Tissue-expander Implant following Mastectomy.

Authors:  Achilles Thoma; Ronen Avram; Arianna Dal Cin; Jessica Murphy; Eric Duku; Feng Xie
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.